News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2018 Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR TCT Daily Staff September 28, 2018